Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Intracranial Aneurysms
Interventions
DEVICE

Flow Re-Direction Endoluminal Device (FRED)

Trial Locations (24)

10019

Mount Sinai Health System, New York

11030

North Shore University Hospital, Manhasset

11794

Stony Brook University Medical Center, Stony Brook

12208

Albany Medical Center, Albany

14203

University at Buffalo, Buffalo

19107

Thomas Jefferson University, Philadelphia

21287

The Johns Hopkins Hospital, Baltimore

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

32207

Lyerly Neurosurgery, Jacksonville

38104

Methodist University Hospital, Memphis

40202

Norton Neuroscience Institute, Louisville

55407

Abbott Northwestern Hospital, Minneapolis

55903

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University, St Louis

77030

Baylor Saint Luke Medical Center, Houston

The Methodist Hospital, Houston

80113

Swedish Medical Center / RIA, Englewood

85013

St. Joseph's Hospital and Medical Center, Phoenix

02111

Tufts Medical Center, Boston

08638

Capital Health Hospital, Trenton

650-0047

Institute of Biomedical Research and Innovation, Kobe

All Listed Sponsors
lead

Microvention-Terumo, Inc.

INDUSTRY

NCT01801007 - Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms | Biotech Hunter | Biotech Hunter